We provide a thorough review and analysis of non-clinical data to ensure regulatory compliance and identify potential gaps. This service is designed to help clients understand the scope of their preclinical development and make informed decisions for the next steps in drug development.

Our experts conduct an in-depth evaluation of your existing preclinical data package to identify any deficiencies or areas for improvement. By performing a detailed gap analysis, we ensure that all necessary studies are completed to meet regulatory requirements and advance your project efficiently.

We offer strategic guidance for new projects by developing customized preclinical strategies tailored to your compound and therapeutic goals. This includes defining the critical path for regulatory approval, optimizing study designs, and ensuring that the development process is streamlined and cost-effective.

Our team assists in selecting the most promising drug candidates from your lead compounds. Using a combination of scientific expertise and strategic insights, we help you identify candidates with the highest potential for success in preclinical and clinical development.

We design robust Proof-of-Concept (PoC) studies that demonstrate the efficacy and safety of your drug candidates in preclinical models. These studies are crucial in determining whether a compound has the potential to move forward into clinical development.

To accelerate the drug discovery process, we design a customized screening cascade that efficiently filters compounds, reducing the time required for preclinical development. This approach enhances productivity by focusing on the most promising candidates early in the development cycle.

Our preclinical project management services ensure seamless execution of your preclinical studies. From planning and resource allocation to monitoring and reporting, we provide end-to-end management to keep your project on track, within budget, and compliant with regulatory timelines.